Label: RODAN AND FIELDS ENHANCEMENTS LIGHT- titanium dioxide, zinc oxide powder
RODAN AND FIELDS ENHANCEMENTS MEDIUM- titanium dioxide, zinc oxide powder
RODAN AND FIELDS ENHANCEMENTS BRONZE- titanium dioxide, zinc oxide powder

  • NDC Code(s): 54111-119-50, 54111-120-50, 54111-121-50
  • Packager: Bentley Laboratories, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 19, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts Active ingredients

    Titanium Dioxide 9.6%
    Zinc Oxide 4.9%

  • Purpose

    Sunscreen

  • Keep out of each of children.

    Keep out of reach of children.

    If product is swallowed, get medical help or contact a Poison Control Center right away.

  • Uses

    • Helps prevent sunburn
  • Warnings

    For external use only

  • Do not use

    on damaged or broken skin

  • When using this product

    keep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor

    if rash occurs

  • Directions

    • Apply liberally 15 minutes before sun exposure
    • Use a water resistant sunscreen if swimming or sweating
    • Reapply at least every 2 hours
    • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum of 15 or higher and other sun protection measures including:
      • Limit time in the sun, especially from 10 a.m. - 2 p.m.
      • Wear long sleeve shirts, pants, hats, and sunglasses
      • Children under 6 months: Ask a doctor
  • Inactive ingredients

    Mica, Polymetylsilsesquioxane, Squalane, Water, Silia, Bismuth Oxychloride, Stearic Acid, Aluminum Hydroxide, Ceramide 3, Cholesterol, Phytosphingosine, Phenoxyethanol, Butylene Glycol, Caprylyl Glycol, Barium Sulfate, Angelica Polymorpha Sinensis Root Extract, HDI/Trimethylol Hexyllactone Crosspolymer, Potassium Sorbate, Hexylene Glycol, Dimethylacrlamide/Acrylic Acid/Polystyrene Ethyl Methacrylate Copolymer, Tranexamic Acid, Triethoxycaprylylsilane, Peat Extract, Trimyristin, Hydrogenated Lecithin, Oligopeptide-10, Tetrapeptide-14, Honey Extrac, Boswellia Serrata Extract, Resveratrol Lecithin, Silver. May contain: Iron Oxides, Titanium Dioxide.

  • Other information

    Protect this product from excessive heat and direct sun.

  • Rodan + Fields ENHANCEMENTS - Light, Medium, Bronze Product Labels

    escription for Change™

    RODAN+FIELDS®
    ENHANCEMENTS

    Mineral Peptides

    BROAD SPECTRUM SPF 20

    RODAN+FIELDS®
    DERMATOLOGISTS

    4g/0.14 Oz.

    Manufactured for Rodan and Fields, LLC 111 Maiden Lane, Suite 400 San Francisco CA 94108 Made in the USA Please Recycle

    visit rodanand fields.com  QUESTIONS OR COMMENTS 1-888-995-5656

    Light
    ENPL004
    08-03-0023

    Medium
    ENPM004
    80-03-0024

    Bronze
    ENPB004
    80-03-0025

    RF MineralPep Light Label

    RF MineralPep Light1 Label

    RF MineralPep Medium Label

    RF MineralPep Bronze Label

    res

  • INGREDIENTS AND APPEARANCE
    RODAN AND FIELDS ENHANCEMENTS  LIGHT
    titanium dioxide, zinc oxide powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54111-119
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.38400 g  in 4 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE0.19600 g  in 4 g
    Inactive Ingredients
    Ingredient NameStrength
    MICA (UNII: V8A1AW0880)  
    POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
    SQUALANE (UNII: GW89575KF9)  
    WATER (UNII: 059QF0KO0R)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    CERAMIDE 3 (UNII: 4370DF050B)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    BARIUM SULFATE (UNII: 25BB7EKE2E)  
    ANGELICA SINENSIS ROOT (UNII: B66F4574UG)  
    HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    TRANEXAMIC ACID (UNII: 6T84R30KC1)  
    TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
    TRIMYRISTIN (UNII: 18L31PSR28)  
    HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
    HONEY (UNII: Y9H1V576FH)  
    INDIAN FRANKINCENSE (UNII: 4PW41QCO2M)  
    RESVERATROL (UNII: Q369O8926L)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    SILVER (UNII: 3M4G523W1G)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54111-119-504 g in 1 JAR; Type 0: Not a Combination Product08/15/2012
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02008/15/2012
    RODAN AND FIELDS ENHANCEMENTS  MEDIUM
    titanium dioxide, zinc oxide powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54111-120
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.38400 g  in 4 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE0.19600 g  in 4 g
    Inactive Ingredients
    Ingredient NameStrength
    MICA (UNII: V8A1AW0880)  
    POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
    SQUALANE (UNII: GW89575KF9)  
    WATER (UNII: 059QF0KO0R)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    CERAMIDE 3 (UNII: 4370DF050B)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    BARIUM SULFATE (UNII: 25BB7EKE2E)  
    ANGELICA SINENSIS ROOT (UNII: B66F4574UG)  
    HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    TRANEXAMIC ACID (UNII: 6T84R30KC1)  
    TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
    TRIMYRISTIN (UNII: 18L31PSR28)  
    HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
    HONEY (UNII: Y9H1V576FH)  
    INDIAN FRANKINCENSE (UNII: 4PW41QCO2M)  
    RESVERATROL (UNII: Q369O8926L)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    SILVER (UNII: 3M4G523W1G)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54111-120-504 g in 1 JAR; Type 0: Not a Combination Product09/05/2012
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02009/05/2012
    RODAN AND FIELDS ENHANCEMENTS  BRONZE
    titanium dioxide, zinc oxide powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54111-121
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.38400 g  in 4 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE0.19600 g  in 4 g
    Inactive Ingredients
    Ingredient NameStrength
    MICA (UNII: V8A1AW0880)  
    POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
    SQUALANE (UNII: GW89575KF9)  
    WATER (UNII: 059QF0KO0R)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    CERAMIDE 3 (UNII: 4370DF050B)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    BARIUM SULFATE (UNII: 25BB7EKE2E)  
    ANGELICA SINENSIS ROOT (UNII: B66F4574UG)  
    HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    TRANEXAMIC ACID (UNII: 6T84R30KC1)  
    TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
    TRIMYRISTIN (UNII: 18L31PSR28)  
    HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
    HONEY (UNII: Y9H1V576FH)  
    INDIAN FRANKINCENSE (UNII: 4PW41QCO2M)  
    RESVERATROL (UNII: Q369O8926L)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    SILVER (UNII: 3M4G523W1G)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54111-121-504 g in 1 JAR; Type 0: Not a Combination Product04/19/2013
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02004/19/2013
    Labeler - Bentley Laboratories, LLC (068351753)
    Registrant - Bentley Laboratories, LLC (068351753)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!